Blaze Bioscience
Biotechnology ResearchWashington, United States11-50 Employees
Blaze Bioscience is a Seattle-based biotechnology company focused on improving outcomes for cancer patients, beginning with pediatric brain cancer surgery. The company uses tumor paint technology, together with its CANVAS Imaging system and CDP Discovery Platform, to enhance the detection, removal, and treatment of cancers, with a particular emphasis on early-stage disease where curative options are more likely. Operating in the biotechnology research sector, Blaze Bioscience positions itself around precision imaging to support surgical decision-making and treatment planning. Its target customers are clinicians and healthcare institutions involved in cancer care, especially brain surgeons and oncology teams seeking more reliable intraoperative guidance. A recent development noted in May 2023 describes Blaze Bioscience exploring tumor paint that lights up cancer cells to assist brain tumor surgery, reflecting continued focus on image-guided oncologic interventions.
1-888-653-2347 
support@leadiq.com 
